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Summary Transient focal lesions in the splenium of the corpus callosum (SCC) have
been associated with antiepileptic drug (AED) treatment. However, the aetiology is
widely unknown. We describe a transient SCC lesion in an epilepsy patient after
abrupt AED reduction. Whole head high-field diffusion tensor imaging (DTI) including
fully automated quantitative fractional anisotropy (FA) analysis was used to get
insight into the pathophysiology of transient SCC lesions.
Our results demonstrate that a reversible loss of directional fibre organisation in
the splenium, likely due to intramyelinic oedema, is the morphological correlate of
transient SCC lesions. We conclude that DTI provides a highly sensitive and quanti-
tative tool to detect subtle and transient loss of fibre integrity associated with AED
treatment.
# 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Transient focal lesions in the splenium of the corpus
callosum (SCC) are a rare finding associated with
antiepileptic drug (AED) treatment.1,2 These
lesions probably do not cause relevant neurological
deficits and they disappear after weeks to months.1
Therefore, it is important to be aware of this rare
phenomenon in order to avoid unnecessary diag-* Corresponding author. Department of Neurology, University of
Mu¨nster, Albert-Schweitzer-Strasse 33, 48149 Mu¨nster, Germany.
Tel.: +49 251 2463527.
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doi:10.1016/j.seizure.2008.01.004nostic and therapeutic intervention. To date, the
aetiology and the pathogenesis of AED associated
transient SCC lesions are unknown. Toxic AED
serum levels and sudden AED reduction have been
related causally,2—4 and a transient vasogenic or
cytotoxic oedema has been hypothesized as the
underlying pathophysiological mechanism.4—7 Typi-
cal MRI findings include an ovoid lesion in the
central portion of the splenium with high signal
intensity on T2-weighted and FLAIR sequences, low
signal intensity on T1-weighted images, no signal
enhancement after Gadolinium infusion and
restricted proton diffusion on diffusion-weighted
images (DWI).2,4. Published by Elsevier Ltd. All rights reserved.
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technique providing the possibility to examine
alterations of the orientation and integrity of neural
fibres in vivo. In epilepsy, DTI has been applied for
different purposes, including the examination of
fibre integrity after callosotomy,8 in temporal lobe
epilepsy9 and in postictal states.10 The fractional
anisotropy (FA) derived from DTI reflects local tissue
properties and has been successfully employed to
assess nerve fibre integrity. However, FA studies
often suffer from relevant disadvantages concerning
image acquisition and data analysis. As clinical FA
measurements are frequently based on single slice
evaluations, intra and inter individual comparisons
are highly dependent on image alignment.11 In the
present study, we used a fully automated approachFigure 1 Upper row:Magnetic resonance images taken durin
a lesion in the splenium of the corpus callosum (hyperintensit
fibre directions for better orientation (red: left—right; green
coded quantitative fractional anisotropy (see colour legend)
reduction from 0.7 (normal) to values less than 0.5 (highly pa
recovery. D: T2 weighted MRI demonstrating the regression of
Fractional anisotropy values of the splenium are in the norm
information in the figure or text, the reader is referred to thfor spatial image normalization and statistical group
comparisons of FA maps on a voxel-by-voxel basis.11
This technique allows for reproducible and observer
independent quantitative analyses of regional FA in
group and single subject studies (for details
see11,12). Here, we report a case of AED associated
transient SCC lesion and present new insights into
the underlying pathophysiological mechanisms.Case report
A 48-year-old woman with pharmacoresistant epi-
lepsy since the age of 41 and an anxiety disorder was
admitted to our epilepsy monitoring unit. She suf-
fered from right hemispheric epilepsy with sensoryg the acute phase of the lesion. A: T2weighted MRI showing
y emphasized by enlargement). B: DTI representing nerve
: anterior—posterior; blue: inferior—superior). C: colour
, the lesion site shows a significant fractional anisotropy
thological for the splenium). Lower row: MRI taken after
the lesion in the splenium. E: Fibre direction resolved. F:
al range. (For interpretation of the references to colour
e web version of the article.)
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Figure 2 Relative decrease of fractional anisotropy
(colour legend) during the acute phase of the lesion
compared to the fractional anisotropy after regression.auras and tonic—clonic seizures of her left arm and
leg, occasionally followed by loss of consciousness
and secondary generalization due to a meningoen-
cephalitis at age 39 years. A brain MRI taken 1 year
before admission had been completely normal.
The neurological examination was unremarkable.
The patient was treated with carbamazepine
(daily dose 1500 mg, serum concentration
12.4 mg/ml) and pregabalin (daily dose 300 mg).
Although both drugs were reduced abruptly to half
of the patient’s regular dose (further reduction
was refused by the patient for personal reasons) at
the beginning of the monitoring period, no sei-
zures occurred. The EEG and FDG-PET were nor-
mal. A neuropsychological evaluation revealed
moderate non-specific mnestic deficits and a mild
impairment of attention and executive functions,
compatible with a post-encephalitic state. There
was no evidence for a disconnection syndrome.
Routine laboratory tests performed at admission
showed increased gamma-GT (131 U/l) and throm-
bocytosis (363 thousand/ml). Electrolytes were
within normal range. Nine days after the beginning
of AED reduction, a brain MRI revealed an ovoid
lesion, 2 cm  1 cm in diameter, in the central
part of the SCC. The lesion was hypointensive
on T1-weighted images and hyperintensive on
T2-weighted and FLAIR images (Fig. 1). DWI
sequences showed a hyperintensive lesion
corresponding to a decreased apparent diffusion
coefficient (ADC). There was no contrast medium
uptake after Gadolinium infusion. In summary,
these findings suggest the presence of a cytotoxic
oedema.
Thirteen days later, a control MRI including FA
analysis11 was performed. For DTI we employed
echo planar imaging (EPI) at 3 Tesla with 20 diffu-
sion directions (36 slices, thickness 3.6 mm, matrix
128  128, in-plane resolution 1.8 mm  1.8 mm).
After correction for eddy currents and spatial
normalization, the FA and fiber direction maps
were calculated with the aid of in-house soft-
ware.11 The SCC lesion showed the same features
on T1-, T2- and FLAIR-weighted images as before
(Figure 1a). DTI revealed a decreased FA in the SCC
indicating loss of directional organisation of the
splenial fibres (Figure 1b and c). The same MRI
protocol was applied another 16 days later again.
Now, the FA map showed complete remission in the
splenium (Figure 1e and f). T1-, T2-, and FLAIR
weighted images revealed a nearly complete
regression of the oedema (Figure 1d). The compar-
ison of the first and the second FA map revealed
that the FA in the centre of the SCC was reduced
by 20—40% during the acute phase of the lesion
(Fig. 2).Discussion
Transient SCC lesions have been reported in patients
with and without epilepsy treated with AEDs2—4,7,13
as well as in other conditions like cerebral infections
where AED treatment is not involved.2,7 Therefore,
transient SCC lesions might be caused by different
factors that lead to a common causal pathway.
However, no pathophysiological hypothesis which
could satisfactorily explain this benign phenomenon
has been identified. We describe a case of a tran-
sient SCC lesion in an epilepsy patient after abrupt
AED reduction. Our case fulfils the characteristic
clinical and MR imaging features of AED associated
SCC lesions reported in the literature.
For the first time, we could show by means of DTI
that a reversible loss of directional fibre organisa-
tion, indicating a myelin lesion, is a pathogenetic
factor in transient SCC lesions. In combination
with the DWI data, our study suggests that the loss
of directional fibre organisation in transient SCC
lesions is likely caused by intramyelinic cytotoxic
oedema.
It has been hypothesized that transient AED
related SCC lesions might be caused by oedema at
other levels like glial oedema.7 Our data do not
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aetiology of AED associated transient SCC lesions
might be multifactorial.
So far, only one DTI based study of transient AED
associated SCC lesions has been available.7 Differ-
ent from our study, the authors could not find loss of
directional fibre organisation which is probably due
to differences in the method of analysis or lesional
changes in time course.
Based on the patient’s clinical course and MRI
findings, we conclude that the abrupt reduction
of carbamazepine (CBZ) and pregabalin, and not
a toxic drug effect was causally related to the
transient SCC lesion. In the literature, CBZ is
most frequently associated with transient SCC
lesions.4,14 It has been shown that CBZ can
enhance the antidiuretic effect of arginine-vaso-
presin (AVP), and that continuous CBZ treatment
leads to reduction of AVP serum levels.15 An imbal-
ance of the AVP mediated fluid-balance system can
contribute to brain oedema.16 Hence, abrupt with-
drawal of CBZ, as performed in long time EEG
monitoring, might lead to short disequilibrium
causing inappropriate antidiuresis and consecutive
brain oedema.5 This might be the cause of the
intramyelinic cytotoxic oedema shown in this
study.
The reversibility of the loss of directional fibre
organisation and the lack of associated clinical
symptoms suggest a mild lesion demanding high
sensitive imaging techniques. The DTI technique
applied in this study11 which is based on FA
obtained from isotropic whole head high-field
DTI by fully automated algorithms provides an
appropriate tool for this purpose. Furthermore,
this case shows for the first time that loss of
directional organisation of the central myelin as
detected by DTI is reversible.Acknowledgement
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